01/11/2025
𝗛𝗼𝘄 𝗺𝘂𝗰𝗵 𝗮𝗲𝗿𝗼𝗯𝗶𝗰 𝗲𝘅𝗲𝗿𝗰𝗶𝘀𝗲 𝗶𝘀 𝗻𝗲𝗲𝗱𝗲𝗱 𝘁𝗼 𝗿𝗲𝗱𝘂𝗰𝗲 𝗺𝗶𝗴𝗿𝗮𝗶𝗻𝗲?
🤕 Migraine, a leading cause of disability affecting over 1.16 billion people worldwide (GBD Collaborators, 2024; Woldeamanuel & Cowan, 2017), contributes to an estimated $1.9 trillion economic burden in 2025 (Woldeamanuel et al., 2025). Given the limitations of pharmacologic therapy and access disparities in headache care (Bentivegna et al., 2023; Lanteri-Minet et al., 2024), scalable interventions like exercise are urgently needed.
📘 A brand-new dose-response meta-analysis by Ogrezeanu et al. (2025, https://pubmed.ncbi.nlm.nih.gov/41085000/) quantified, for the first time, a therapeutic dose of aerobic exercise for migraine and revealed a U-shaped dose–response curve.
🏃♀️Aerobic training significantly reduced both:
⬇️ Migraine pain intensity (SMD = –1.10),
⬇️ Attack frequency (SMD = –0.79),
✅ with optimal benefits achieved at 900–950 cumulative minutes of moderate-intensity aerobic exercise delivered over 10–11 weeks (equivalent to ~30 minutes, three sessions per week at 50–70% VO₂peak, infographic below).
👉 These findings build on earlier reviews supporting exercise efficacy (La Touche et al., 2020; Varangot-Reille et al., 2022; Reina-Varona et al., 2024) but are the first to define specific exercise dosing guidelines.
👉 Subgroup analyses suggest s*x differences and migraine chronicity modify treatment response:
▶️ Greater effects in episodic migraine than in chronic migraine (Ogrezeanu et al., 2025),
▶️ Larger reductions in attack frequency among women, consistent with s*x-based pain sensitivity and hormonal influences (Amin et al., 2018).
🏃♂️➡️ In an editorial, Woldeamanuel emphasizes a precision medicine approach, advocating graded exercise pacing to prevent overexertion cycles common in migraine patients (Andrews et al., 2012; Nielson et al., 2014). For sedentary individuals or those with kinesiophobia (fear of movement) (Benatto et al., 2019), exercise initiation at low intensity (40–50% VO₂peak) using time-contingent progression strategies is recommended (La Touche et al., 2023).
Importantly, exercise efficacy may be enhanced by addressing sleep and circadian regulation, as morning light exposure combined with exercise improves migraine stability (Youngstedt et al., 2016; Ong et al., 2018; Woldeamanuel et al., 2023).
💡 Practical tips:
☀️ Circadian Alignment: Encourage morning exercise with outdoor light exposure to stabilize sleep wake cycles.
😴 Lifestyle Integration: Advise consistent sleep (7-8 hoursnightly), strict meals at fixed daytimes, and hydration tracking.
⬆️ For complex cases with comorbid disorders—such as vestibular migraine, postural orthostatic tachycardia syndrome (POTS), or exercise intolerance—modifications including recumbent cycling, hydration strategies, compression garments, vestibular rehabilitation (gaze stabilization or balance training), and neck strengthening (Sun et al., 2022; Benatto et al., 2022) may improve tolerance.
🏋️♀️ Although promising, the review evidence is rated low to very low certainty due to heterogeneity and small sample sizes. In future studies, a comparison of aerobic vs. strength training is mandatory, as resistance training may be equally or more effective (Woldeamanuel & Oliveira, 2022; Wang et al., 2025; Sari Aslani et al., 2022).
✅ Conclusion
Exercise is positioned as a first-line behavioral intervention for migraine prevention. A personalized prescription of 900–950 cumulative minutes of moderate-intensity aerobic exercise over 10–11 weeks is supported by current evidence. Pharmacologic therapies should be used as bridge therapies to enable long-term lifestyle interventions that improve self-efficacy and disease control (Irby et al., 2016).
📚 References
Amin FM, Aristeidou S, Baraldi C, et al. (2018). J Headache Pain, 19:83.
Andrews NE, Strong J, Meredith PJ. (2012). Arch Phys Med Rehabil, 93:2109–2121.
Benatto MT, Bevilaqua-Grossi D, Carvalho GF, et al. (2019). Pain Med, 20:846–851.
Benatto MT, Florencio LL, Bragatto MM, et al. (2022). BMC Neurol, 22:126.
Bentivegna E, Onan D, Martelletti P. (2023). Neurol Ther, 12:337–342.
GBD 2021 Diseases and Injuries Collaborators. (2024). Lancet, 403:2133–2161.
Irby MB, Bond DS, Lipton RB, et al. (2016). Headache, 56:357–369.
La Touche R, Fernández Pérez JJ, Proy Acosta A, et al. (2020). Scand J Med Sci Sports, 30:965–982.
La Touche R, Fierro-Marrero J, Sánchez-Ruiz I, et al. (2023). J Headache Pain, 24:68.
Lanteri-Minet M, Leroux E, Katsarava Z, et al. (2024). J Headache Pain, 25:134.
Nielson WR, Jensen MP, Karsdorp PA, Vlaeyen JWS. (2014). Clin J Pain, 30:639–645.
Ogrezeanu DC, Núñez-Cortés R, Salazar-Méndez J, et al. (2025). Headache.
Ong JC, Taylor HL, Park M, et al. (2018). Headache, 58:1040–1051.
Reina-Varona Á, Madroñero-Miguel B, Fierro-Marrero J, et al. (2024). Headache, 64:873–900.
Sari Aslani P, Hassanpour M, Razi O, et al. (2022). Sport Sci Health, 18:433–443.
Sun L, Li G, Liu F, et al. (2022). Rev Neurol (Paris), 178:370–376.
Varangot-Reille C, Suso-Martí L, Romero-Palau M, et al. (2022). J Pain, 23:1099–1122.
Wang Y, Zhu X, Liang Y. (2025). Am J Lifestyle Med.
Woldeamanuel YW, Cowan RP. (2017). J Neurol Sci, 372:307–315.
Woldeamanuel YW, Oliveira ABD. (2022). J Headache Pain, 23:134.
Woldeamanuel YW, Palesh O, Cowan RP. (2023). Ann Neurol, 94:S152.
Woldeamanuel YW, Fani M, Javaheri E, et al. (2025). Ann Neurol, 98:S205.
Woldeamanuel YW. (2025). Headache, 00:1–4.
Youngstedt SD, Kline CE, Elliott JA, et al. (2016). J Circadian Rhythms, 14:2.